Treat a broader areA of wrinkles
This injectable treatment is made from the same neurotoxin (botulinum toxin type A) as Botox®. Dysport® (formally Reloxin) received the approval of the U.S. Food and Drug Administration (FDA) for use as a wrinkle treatment in the spring of 2009 for smoothing out facial folds and lines. Dysport is similar toBotox® and Xeomin®, although some research suggests that Dysport may be faster-acting and longer-lasting. It also spreads farther from the injection site, thus allowing a broader area of small wrinkles (such as the “crow’s feet” lines that splay out from the corners of the eyes) to be treated with fewer injections. Like Botox & Xeomin, Dysport is injected directly into the facial muscles beneath the lines of the face. Usually, only 3 to 5 injections are needed to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines). Most people find the injections almost painless, so a local anesthetic is usually not needed.Learn More!